Mannatech, Incorporated

Description

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

About

CEO
Mr. Landen Granvel Fredrick
Employees
213
Instrument type
Common Stock
Sector
Consumer Defensive
Industry
Food Distribution
MIC code
XNCM
Address
1410 Lakeside Parkway, Flower Mound, TX 75028, United States
Phone
972 471 7400
Website
Chart Image
× Enlarged Chart
Oscillators
No data available
Summary
No data available
Moving Averages
No data available

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Nov 11, 2025
Aug 11, 2025
May 12, 2025
Mar 26, 2025
May 12, 2023 0.32

Earnings estimate

Number of analysts
Average estimate
Low estimate
High estimate
Last year EPS
[stock_revenue_estimate]

Growth estimates

Current qtr
Next qtr.
Current year
Next year
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 131.96M 137.21M 159.76M 151.41M 157.73M
Cost of revenue 29.09M 33.06M 34.15M 35.51M 31.55M
Gross profit 102.87M 104.15M 125.61M 115.90M 126.18M
Operating expense
Research & development
Selling general and admin 48.61M 47.44M 29.43M 27.85M 30.82M
Other operating expenses 53.59M 55.48M 85.42M 81.58M 86.83M
Operating income -964,000 -405,000 9.05M 4.49M 6.43M
Non operating interest income
Income 4,000 88,000 66,000 -16,000
Expense
Other income expense -170,000 -162,000 -223,000 1.15M -681,000
Pretax income -1.13M -479,000 8.89M 5.73M 5.74M
Tax provision 1.11M 4.01M -950,000 -536,000 2.45M
Net income -2.24M -4.49M 9.84M 6.26M 3.29M
Basic EPS -1.20 -2.35 4.95 2.80 1.38
Diluted EPS -1.20 -2.35 4.71 2.77 1.35
Basic average shares 1.87M 1.91M 1.99M 2.24M 2.39M
Diluted average shares 1.87M 1.91M 1.99M 2.24M 2.39M
EBITDA 664,000 1.22M 10.77M 6.48M 8.52M
Net income from continuing op. -2.24M -4.49M 9.84M 6.26M 3.29M
Minority interests
Preferred stock dividends

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 41.21M 49.13M 59.61M 65.26M 62.93M
Current assets
Cash
Cash equivalents
Cash and cash equivalents 7.73M 13.78M 24.19M 22.21M 24.76M
Other short term investments
Accounts receivable 91,000 218,000 90,000 186,000 955,000
Other receivables
Inventory 14.54M 14.73M 12.02M 12.83M 10.15M
Prepaid assets 2.89M 2.96M 2.24M
Restricted cash 938,000 944,000 944,000 944,000 943,000
Assets held for sale
Hedging assets
Other current assets 1.77M 2.39M 2.89M 2.96M 2.24M
Non current assets
Properties 1.24M 182,000 177,000 260,000 269,000
Land and improvements
Machinery furniture equipment 51.48M 51.60M 50.79M 50.94M 50.05M
Construction in progress 1.49M 1.68M 3.26M 3.06M 3.07M
Leases 3.87M 4.08M 4.29M 4.51M 4.23M
Accumulated depreciation -52.63M -52.48M -52.37M -51.21M -49.29M
Goodwill 200,000 200,000
Investment properties
Financial assets
Intangible assets 200,000 200,000
Investments and advances 2.20M 2.30M 2.40M 2.60M 1.60M
Other non current assets 2.40M 2.02M 3.53M 5.72M 6.38M
Total liabilities 30.72M 34.95M 35.21M 39.36M 35.65M
Current liabilities
Accounts payable 4.01M 4.36M 3.97M 4.80M 3.53M
Accrued expenses 2.70M 3.24M 4.08M 3.55M 3.49M
Short term debt 2.17M 1.92M 1.77M 2.70M 2.45M
Deferred revenue 5.30M 5.75M 5.64M 6.18M 4.77M
Tax payable 1.72M 3.57M 2.47M 1.89M 2.62M
Pensions 1.71M 1.74M 2.57M 1.88M 2.31M
Other current liabilities
Non current liabilities
Long term debt 3.56M 4.29M 66,000 129,000 539,000
Provision for risks and charges
Deferred liabilities 3,000 3,000
Derivative product liabilities
Other non current liabilities -14,000 26,000 5.05M 7.25M 6.21M
Shareholders equity
Common stock
Retained earnings -1.30M 1.69M 7.71M 2.21M -690,000
Other shareholders equity -1.02M -208,000 2.34M 5.15M 3.76M
Total shareholders equity 10.48M 14.18M 24.41M 25.97M 27.28M
Additional paid in capital 33.31M 33.38M 33.28M 33.80M 34.14M
Treasury stock 20.51M 20.68M 18.92M 15.19M 9.94M
Minority interest

Cash flow statement

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Operating Activities
Net Income-2.24M-4.49M9.84M6.26M3.29M-3.89M-1.79M-586,0005.84M6.50M3.17M-1.39M-20.66M-10.62M-17.37M-12.63M6.59M32.39M28.65M19.55M8.79M1.89M-3.66M-7.35M10.80M10.10M
Depreciation1.63M1.63M1.72M1.99M2.09M2.06M1.86M1.90M1.79M1.61M2.12M4.76M10.70M11.52M12.33M12.31M10.24M4.96M3.91M3.10M3.18M3.99M3.92M3.74M3.00M2.20M
Deferred Taxes121,0001.23M-1.73M-280,0001.06M1.17M2.14M-1.27M154,000-1.66M-2.11M583,000-380,000-2.04M761,000-3.06M-2.44M5.36M3.09M156,000-2.06M219,000-1.71M298,000-800,000900,000
Stock-Based Compensation278,000337,000260,000334,000734,0001.15M490,000690,000592,000678,000173,000209,000356,000630,000636,000727,000
Other Non-Cash Items1.90M1.87M2.20M1.94M1.73M24,000658,000646,000-84,000209,000-17.00M-8.35M1.58M1.32M2.39M1.16M1,000200,000
Accounts Receivable-433,000-183,000516,000-227,000-860,000240,000378,000-2.09M-266,000-713,000589,000-36,00088,0007.36M-4.93M-1.08M-467,000-2.62M-161,000-4.42M822,000-278,0002.32M-2.60M-200,000400,000
Accounts Payable-351,000392,000-828,0001.27M-3.20M716,000710,0002.55M-1.56M-709,000883,000-646,000-730,000-5.79M6.25M1.41M
Other Assets & Liabilities-472,000-2.35M24,000-3.33M1.75M-6.02M2.49M-3.60M-323,000525,0001.80M593,0002.06M2.07M-3.79M-10.45M2.88M1.52M3.35M5.42M6.85M1.80M6.93M-1.08M-8.30M2.00M
Operating Cash Flow436,000-1.57M12.01M7.96M6.60M-4.57M6.29M-2.38M6.89M6.87M6.54M4.28M-25.57M-5.23M-4.53M-11.46M19.19M42.77M38.83M23.81M17.58M7.62M7.79M-7.00M4.50M15.80M
Investing Activities
Capital Expenditures-748,000-1.06M-650,000-949,000-1.22M-2.34M-1.34M-2.29M-1.98M-1.53M-602,000-379,000-777,000-1.77M-2.76M-5.61M-13.41M-26.70M-13.11M-7.24M-892,000-976,000-1.32M-4.11M-3.20M-4.60M
Net Intangibles
Net Acquisitions
Purchase of Investments-7.40M1,000-8.01M-276,000-7.08M
Sale of Investments20.35M12.42M1,0002.29M
Investing Cash Flow-747,000-1.06M-650,000-947,000-1.22M-2.28M-1.34M-2.29M-1.98M-1.53M-601,000-268,000-623,0001.93M-1.29M7.20M-7.84M-35.69M-15.65M-12.49M-12.50M-1.29M-1.19M-1.69M-4.60M-4.50M
Financing Activities
Long-Term Debt Issuance2.24M1.64M
Long-Term Debt Payments-991,000-817,000-435,000-2.87M-1.22M-1.54M-1.57M-1.55M-1.53M-1.54M-1.58M-1.07M-1.16M-1.39M-473,000-115,000
Other Financing Charges-1.55M-1.53M32,00035,000-1.07M100,000497,000-500,000-600,000-2.60M
Financing Cash Flow-1.92M-4.33M-9.83M-9.92M-2.71M-12.17M-3.15M-4.05M-1.41M-1.51M-1.54M-2.15M-1.17M-1.39M-1.53M-5.94M-9.27M-13.96M-13.76M-1.96M2.92M241,000-137,000-1.30M-12.50M
Other Cash Details
End Cash Position9.39M15.20M25.63M27.50M31.00M30.58M46.76M28.69M31.99M28.00M20.40M14.38M18.06M21.58M17.37M30.95M47.10M45.70M56.21M44.20M28.29M17.69M9.93M5.74M11.60M800,000
Income Tax Paid2.55M715,000137,000989,000996,000800,0001.69M1.78M4.66M4.25M2.23M876,000480,0007.13M2.44M
Interest Paid100,00032,00031,00071,000126,00064,00068,000113,00089,000119,000137,000171,000167,000117,00050,00017,000
Free Cash Flow-3.12M-3.66M10.12M5.08M3.70M-2.56M8.98M-2.31M2.41M7.89M7.93M-1.91M-3.65M2.23M-13.11M-25.50M4.37M13.19M29.85M22.62M19.31M8.72M6.10M-8.67M1.60M13.60M

Top Institutional Holders

Holder Date Reported Shares Value % Held
Vanguard Total Stock Market Index Fund Sep 30, 2024 30,953 355,959 1.64%
Bridgeway Funds Inc-Ultra Small Company Fund Sep 30, 2024 23,388 268,962 1.24%
Bridgeway Funds Inc-Ultra Small Company Market Fund Sep 30, 2024 8,298 95,427 0.44%
Bridgeway Fds Inc-Omni Small Cap Value Fund Sep 30, 2024 8,378 96,347 0.44%
Vanguard Extended Market Index Fund Sep 30, 2024 7,559 86,928 0.40%
EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF Sep 30, 2024 5,650 64,975 0.30%
Fidelity Extended Market Index Fund Nov 30, 2024 5,001 57,511 0.27%
Dimensional ETF Tr-Dimensional U.S. Targeted Value ETF Oct 31, 2024 2,523 29,014 0.13%
Fidelity NASDAQ Composite Index Fund Nov 30, 2024 1,393 16,019 0.07%
Fidelity Series Total Market Index Fund Nov 30, 2024 1,317 15,145 0.07%
Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of Directors Article
Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of Directors
FLOWER MOUND, Texas--(BUSINESS WIRE)--Robert A. Toth Appointed as Vice Chairman of Mannatech's Board of Directors.
Business Wire Neutral
Nov 26, 2024
Mannatech Reports Financial Results for Third Quarter 2024 Article
Mannatech Reports Financial Results for Third Quarter 2024
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measu.
Business Wire Neutral
Nov 12, 2024
Mannatech Reports Financial Results for Second Quarter 2024 Article
Mannatech Reports Financial Results for Second Quarter 2024
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measure.
Business Wire Neutral
Aug 13, 2024
Scroll to Top

Markets

Crypto

how to invest

Who we are